MRA National Coverage Decision Extended To Renal, Aortoiliac Arteries
This article was originally published in The Gray Sheet
Executive Summary
Sensitivity and specificity ranges exceeding 80% for imaging renal and aortoiliac arteries with magnetic resonance angiography contributed to CMS' decision to expand national coverage for MRA
You may also be interested in...
AHRQ Brain Tumor MRS Tech Assessment Makes NCD Reversal Doubtful
The limited availability of magnetic resonance spectroscopy (MRS) for diagnosing brain tumors has made it difficult to pursue the types of large clinical trials necessary for obtaining national coverage, according to an 1AHRQ tech assessment
AHRQ Brain Tumor MRS Tech Assessment Makes NCD Reversal Doubtful
The limited availability of magnetic resonance spectroscopy (MRS) for diagnosing brain tumors has made it difficult to pursue the types of large clinical trials necessary for obtaining national coverage, according to an 1AHRQ tech assessment
Angiography Coverage Should Be Formally Extended To Renal Arteries – ACR
Strengthening language in Medicare's national coverage determination on magnetic resonance angiography to include renal and aortoiliac arteries would ensure that local carriers do not deny procedures separate from AAA repair, according to radiologists